For research use only. Not for therapeutic Use.
BCL6-IN-5 is a potent BCL6 inhibitor exacted from patent WO2018215801A1, example 1n, has a pIC50 of 5.82[1].
Catalog Number | I045746 |
CAS Number | 2253878-09-8 |
Synonyms | 5-[(2,5-dichloropyrimidin-4-yl)amino]-3-(3-hydroxy-3-methylbutyl)-1-methylbenzimidazol-2-one |
Molecular Formula | C17H19Cl2N5O2 |
Purity | ≥95% |
InChI | InChI=1S/C17H19Cl2N5O2/c1-17(2,26)6-7-24-13-8-10(4-5-12(13)23(3)16(24)25)21-14-11(18)9-20-15(19)22-14/h4-5,8-9,26H,6-7H2,1-3H3,(H,20,21,22) |
InChIKey | NKMQWLPBEJJYCN-UHFFFAOYSA-N |
SMILES | CC(C)(CCN1C2=C(C=CC(=C2)NC3=NC(=NC=C3Cl)Cl)N(C1=O)C)O |
Reference | [1]. Benjamin Richard BELLENIE, et al. Benzimidazolone derived inhibitors of bcl6. WO2018215801A1. |